Arcutis Biotherapeutics (ARQT) Current Leases (2020 - 2025)
Historic Current Leases for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Q1 2025 value amounting to $842000.0.
- Arcutis Biotherapeutics' Current Leases rose 1137.57% to $842000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $842000.0, marking a year-over-year increase of 1137.57%. This contributed to the annual value of $820000.0 for FY2024, which is 1156.46% up from last year.
- As of Q1 2025, Arcutis Biotherapeutics' Current Leases stood at $842000.0, which was up 1137.57% from $820000.0 recorded in Q4 2024.
- In the past 5 years, Arcutis Biotherapeutics' Current Leases ranged from a high of $842000.0 in Q1 2025 and a low of $106000.0 during Q2 2021
- Moreover, its 5-year median value for Current Leases was $685500.0 (2023), whereas its average is $627750.0.
- As far as peak fluctuations go, Arcutis Biotherapeutics' Current Leases surged by 85625.0% in 2021, and later surged by 1137.57% in 2025.
- Arcutis Biotherapeutics' Current Leases (Quarter) stood at $433000.0 in 2021, then soared by 51.73% to $657000.0 in 2022, then grew by 11.87% to $735000.0 in 2023, then grew by 11.56% to $820000.0 in 2024, then rose by 2.68% to $842000.0 in 2025.
- Its Current Leases was $842000.0 in Q1 2025, compared to $820000.0 in Q4 2024 and $798000.0 in Q3 2024.